ALNYLAM PHARMACEUTICALS, INC. Investment Income, Interest
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Investment Income, Interest of $28.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-07-30
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2026-06-30 was $28.14M, a 2.39% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2025-12-31 was $26.63M, a 14.15% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2025-09-30 was $28.68M, a 10.78% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2025-06-30 was $27.49M, a 5.81% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for fiscal 2025 was $111.47M, a 8.63% decline from fiscal 2024.
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for fiscal 2024 was $121.99M, a 27.66% increase from fiscal 2023.
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for fiscal 2023 was $95.56M, a 285.20% increase from fiscal 2022.
- ALNYLAM PHARMACEUTICALS, INC. investment income, interest for fiscal 2022 was $24.81M, a 1471.12% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.14M 10-Q · filed 2026-07-30 | $54.74M 10-Q · filed 2026-07-30 | ||
| 2025-12-31 | $26.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $55.31M derived: sum of 2 quarters · filed 2026-02-12 | $82.80M derived: sum of 3 quarters · filed 2026-07-30 | $111.47M 10-K · filed 2026-02-12 |
| 2025-09-30 | $28.68M 10-Q · filed 2025-10-30 | $56.17M derived: sum of 2 quarters · filed 2026-07-30 | $84.84M 10-Q · filed 2025-10-30 | $115.86M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $27.49M 10-Q · filed 2026-07-30 | $56.16M 10-Q · filed 2026-07-30 | $87.18M derived: sum of 3 quarters · filed 2026-07-30 | $119.32M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $28.67M 10-Q · filed 2025-05-01 | $59.69M derived: sum of 2 quarters · filed 2026-02-12 | $91.84M derived: sum of 3 quarters · filed 2026-02-12 | $121.02M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-12-31 | $31.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $63.16M derived: sum of 2 quarters · filed 2026-02-12 | $92.35M derived: sum of 3 quarters · filed 2026-02-12 | $121.99M 10-K · filed 2026-02-12 |
| 2024-09-30 | $32.15M 10-Q · filed 2025-10-30 | $61.33M derived: sum of 2 quarters · filed 2025-10-30 | $90.97M 10-Q · filed 2025-10-30 | $121.38M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $29.18M 10-Q · filed 2025-07-31 | $58.83M 10-Q · filed 2025-07-31 | $89.23M derived: sum of 3 quarters · filed 2026-02-12 | $114.66M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $29.64M 10-Q · filed 2025-05-01 | $60.05M derived: sum of 2 quarters · filed 2026-02-12 | $85.48M derived: sum of 3 quarters · filed 2026-02-12 | $106.55M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $30.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $55.83M derived: sum of 2 quarters · filed 2026-02-12 | $76.91M derived: sum of 3 quarters · filed 2026-02-12 | $95.56M 10-K · filed 2026-02-12 |
| 2023-09-30 | $25.43M 10-Q · filed 2024-10-31 | $46.50M derived: sum of 2 quarters · filed 2024-10-31 | $65.16M 10-Q · filed 2024-10-31 | $79.23M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $21.07M 10-Q · filed 2024-08-01 | $39.73M 10-Q · filed 2024-08-01 | $53.81M derived: sum of 3 quarters · filed 2025-02-13 | $61.63M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $18.66M 10-Q · filed 2024-05-02 | $32.73M derived: sum of 2 quarters · filed 2025-02-13 | $40.55M derived: sum of 3 quarters · filed 2025-02-13 | $42.45M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $14.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $21.90M derived: sum of 2 quarters · filed 2025-02-13 | $23.80M derived: sum of 3 quarters · filed 2025-02-13 | $24.81M 10-K · filed 2025-02-13 |
| 2022-09-30 | $7.82M 10-Q · filed 2023-11-02 | $9.72M derived: sum of 2 quarters · filed 2023-11-02 | $10.73M 10-Q · filed 2023-11-02 | $11.23M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $1.90M 10-Q · filed 2023-08-03 | $2.91M 10-Q · filed 2023-08-03 | $3.41M derived: sum of 3 quarters · filed 2024-02-15 | $3.63M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $1.01M 10-Q · filed 2023-05-04 | $1.51M derived: sum of 2 quarters · filed 2024-02-15 | $1.73M derived: sum of 3 quarters · filed 2024-02-15 | $2.14M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $720.00K derived: sum of 2 quarters · filed 2024-02-15 | $1.13M derived: sum of 3 quarters · filed 2024-02-15 | $1.58M 10-K · filed 2024-02-15 |
| 2021-09-30 | $225.00K 10-Q · filed 2021-10-28 | $634.00K derived: sum of 2 quarters · filed 2021-10-28 | $1.08M 10-Q · filed 2021-10-28 | $2.18M derived: sum of 4 quarters · filed 2022-04-28 |
| 2021-06-30 | $409.00K 10-Q · filed 2021-08-03 | $859.00K 10-Q · filed 2021-08-03 | $1.95M derived: sum of 3 quarters · filed 2022-04-28 | $4.02M derived: sum of 4 quarters · filed 2022-04-28 |
| 2021-03-31 | $450.00K 10-Q · filed 2022-04-28 | $1.54M derived: sum of 2 quarters · filed 2022-04-28 | $3.61M derived: sum of 3 quarters · filed 2022-04-28 | $6.78M derived: sum of 4 quarters · filed 2022-04-28 |
| 2020-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $3.16M derived: sum of 2 quarters · filed 2022-02-10 | $6.33M derived: sum of 3 quarters · filed 2022-02-10 | $11.81M 10-K · filed 2022-02-10 |
| 2020-09-30 | $2.07M 10-Q · filed 2021-10-28 | $5.24M derived: sum of 2 quarters · filed 2021-10-28 | $10.72M 10-Q · filed 2021-10-28 | $17.97M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-06-30 | $3.17M 10-Q · filed 2021-08-03 | $8.64M 10-Q · filed 2021-08-03 | $15.90M derived: sum of 3 quarters · filed 2022-02-10 | $25.79M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-03-31 | $5.48M 10-Q · filed 2021-04-29 | $12.73M derived: sum of 2 quarters · filed 2022-02-10 | $22.62M derived: sum of 3 quarters · filed 2022-02-10 | $31.40M derived: sum of 4 quarters · filed 2022-02-10 |
| 2019-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $17.14M derived: sum of 2 quarters · filed 2022-02-10 | $25.92M derived: sum of 3 quarters · filed 2022-02-10 | $33.45M 10-K · filed 2022-02-10 |
| 2019-09-30 | $9.89M 10-Q · filed 2020-11-05 | $18.67M derived: sum of 2 quarters · filed 2020-11-05 | $26.20M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $8.78M 10-Q · filed 2020-08-06 | $16.31M 10-Q · filed 2020-08-06 | ||
| 2018-12-31 | $29.26M 10-K · filed 2021-02-11 | |||
| 2013-03-31 | $224.00K 10-Q · filed 2013-05-07 | $446.00K derived: sum of 2 quarters · filed 2013-05-07 | $707.00K derived: sum of 3 quarters · filed 2013-05-07 | $978.00K derived: sum of 4 quarters · filed 2013-05-07 |
| 2012-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $483.00K derived: sum of 2 quarters · filed 2013-02-19 | $754.00K derived: sum of 3 quarters · filed 2013-02-19 | $977.00K 10-K · filed 2013-02-19 |
| 2012-09-30 | $261.00K 10-Q · filed 2012-11-05 | $532.00K derived: sum of 2 quarters · filed 2012-11-05 | $755.00K 10-Q · filed 2012-11-05 | $991.00K derived: sum of 4 quarters · filed 2013-05-07 |
| 2012-06-30 | $271.00K 10-Q · filed 2012-08-08 | $494.00K 10-Q · filed 2012-08-08 | $730.00K derived: sum of 3 quarters · filed 2013-05-07 | $995.00K derived: sum of 4 quarters · filed 2013-05-07 |
| 2012-03-31 | $223.00K 10-Q · filed 2013-05-07 | $459.00K derived: sum of 2 quarters · filed 2013-05-07 | $724.00K derived: sum of 3 quarters · filed 2013-05-07 | $1.05M derived: sum of 4 quarters · filed 2013-05-07 |
| 2011-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $501.00K derived: sum of 2 quarters · filed 2013-02-19 | $823.00K derived: sum of 3 quarters · filed 2013-02-19 | $1.21M 10-K · filed 2013-02-19 |
| 2011-09-30 | $265.00K 10-Q · filed 2012-11-05 | $587.00K derived: sum of 2 quarters · filed 2012-11-05 | $969.00K 10-Q · filed 2012-11-05 | $1.44M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $322.00K 10-Q · filed 2012-08-08 | $704.00K 10-Q · filed 2012-08-08 | $1.18M derived: sum of 3 quarters · filed 2013-02-19 | $1.78M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $382.00K 10-Q · filed 2012-05-03 | $854.00K derived: sum of 2 quarters · filed 2013-02-19 | $1.46M derived: sum of 3 quarters · filed 2013-02-19 | $2.10M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $1.07M derived: sum of 2 quarters · filed 2013-02-19 | $1.72M derived: sum of 3 quarters · filed 2013-02-19 | $2.31M 10-K · filed 2013-02-19 |
| 2010-09-30 | $602.00K 10-Q · filed 2011-11-03 | $1.24M derived: sum of 2 quarters · filed 2011-11-03 | $1.83M 10-Q · filed 2011-11-03 | $2.68M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | $641.00K 10-Q · filed 2011-08-03 | $1.23M 10-Q · filed 2011-08-03 | $2.07M derived: sum of 3 quarters · filed 2012-02-13 | $3.11M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | $590.00K 10-Q · filed 2011-05-05 | $1.43M derived: sum of 2 quarters · filed 2012-02-13 | $2.47M derived: sum of 3 quarters · filed 2012-02-13 | $3.93M derived: sum of 4 quarters · filed 2012-02-13 |
| 2009-12-31 | $843.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $1.88M derived: sum of 2 quarters · filed 2012-02-13 | $3.34M derived: sum of 3 quarters · filed 2012-02-13 | $5.38M 10-K · filed 2012-02-13 |
| 2009-09-30 | $1.04M 10-Q · filed 2010-11-04 | $2.49M derived: sum of 2 quarters · filed 2010-11-04 | $4.54M 10-Q · filed 2010-11-04 | |
| 2009-06-30 | $1.46M 10-Q · filed 2010-08-05 | $3.51M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $14.41M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |